{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "LEAD: Abuse and mistreatment of medical students are widespread and often leave long-lasting emotional scars that may affect their care of patients as physicians, new studies being published today show.", "headline": {"main": "Wide Abuse of Medical Students Found"}, "abstract": null, "print_page": "7", "word_count": 1020, "_id": "4fd19b6c8eb7c8105d6ac43a", "snippet": "LEAD: Abuse and mistreatment of medical students are widespread and often leave long-lasting emotional scars that may affect their care of patients as physicians, new studies being published today show.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1990/01/26/us/wide-abuse-of-medical-students-found.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "JOURNAL OF THE AMERICAN MEDICAL ASSN"}, {"name": "subject", "value": "MEDICAL SCHOOLS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"firstname": "Lawrence", "middlename": "K.", "lastname": "ALTMAN", "rank": 1, "role": "reported", "organization": ""}], "original": "By LAWRENCE K. ALTMAN"}, "document_type": "article", "pub_date": "1990-01-26T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Financial Desk", "lead_paragraph": "LEAD: The Securities and Exchange Commission suspended trading today in the stock of the Bolar Pharmaceutical Company for the next 10 days. The move was in response to reports that the New York-based generic drug manufacturer had provided false test data to Government health officials about one of its products.", "headline": {"main": "S.E.C. Halts Bolar's Stock"}, "abstract": null, "print_page": "3", "word_count": 182, "_id": "4fd191f68eb7c8105d69aafc", "snippet": "LEAD: The Securities and Exchange Commission suspended trading today in the stock of the Bolar Pharmaceutical Company for the next 10 days. The move was in response to reports that the New York-based generic drug manufacturer had provided false test...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1990/01/26/business/sec-halts-bolar-s-stock.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "BOLAR PHARMACEUTICAL CO"}, {"name": "organizations", "value": "SECURITIES AND EXCHANGE COMMISSION"}, {"name": "subject", "value": "STOCKS (CORPORATE)"}, {"name": "subject", "value": "GENERIC AND BRAND NAME PRODUCTS"}, {"name": "subject", "value": "FALSIFICATION OF DATA"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "DYAZIDE (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "Special to The New York Times"}, "document_type": "article", "pub_date": "1990-01-26T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 2, "offset": 0, "time": 28}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}